Bone Biologics Corp
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$3.2M | -$4.2M | -$9.4M | -$3.7M | -$1.1M |
| Operating expenses | $3.2M | $4.2M | $9.4M | $3.7M | $1.1M |
| Cash from operations | -$2.7M | -$4.1M | -$9.6M | -$3.6M | -$1.2M |
| Total assets | $5.8M | $3.9M | $3.7M | $8.5M | $6.7M |
| Total liabilities | $418,587 | $377,712 | $831,402 | $2.5M | $99,909 |
Shares outstanding 1.8M · Free float 94.1%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.